IDYA vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

IDYA

61.4
AI Score
VS
IDYA Wins

PCRX

58.6
AI Score

Investment Advisor Scores

IDYA

61score
Recommendation
HOLD

PCRX

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IDYA PCRX Winner
Forward P/E 4.649 6.25 IDYA
PEG Ratio 0 11.2121 Tie
Revenue Growth 55.4% 6.2% IDYA
Earnings Growth 0.0% -30.0% IDYA
Tradestie Score 61.4/100 58.6/100 IDYA
Profit Margin -74.8% 2.0% PCRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IDYA 1M: -7.0% · 3M: -5.1% PCRX 1M: -5.2% · 3M: -1.5%

Current Technical Phase

IDYA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.3 · Price: $37.36

PCRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $25.21

Fundamentals Snapshot

Metric IDYA PCRX
Market Cap — —
Forward P/E -9.3 7.3
Trailing P/E — 71.5
Revenue (TTM) — —
Revenue Growth 0.6% 0.1%
Gross Margin -0.6% 0.8%
Operating Margin -13.8% 0.1%
EPS -1.89 0.35
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IDYA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.